Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Unchalee Permsuwan, Kednapa Thavorn, Piyameth Dilokthornsakul, Surasak Saokaew & Nathorn Chaiyakunapruk. (2017) Cost-effectiveness of insulin detemir versus insulin glargine for Thai type 2 diabetes from a payer’s perspective. Journal of Medical Economics 20:9, pages 991-999.
Read now
Read now
Rhodri Saunders, Jean Lian, Boris Karolicki & William Valentine. (2014) The cost-effectiveness and budget impact of stepwise addition of bolus insulin in the treatment of type 2 diabetes: evaluation of the FullSTEP trial. Journal of Medical Economics 17:12, pages 827-836.
Read now
Read now
Richard F. Pollock, Bradley H. Curtis & William J. Valentine. (2012) A long-term analysis evaluating the cost-effectiveness of biphasic insulin lispro mix 75/25 and mix 50/50 versus long-acting basal insulin analogs in the United States. Journal of Medical Economics 15:4, pages 766-775.
Read now
Read now
Dong-Churl Suh & Mark Aagren. (2011) Cost–effectiveness of insulin detemir: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 11:6, pages 641-655.
Read now
Read now
Articles from other publishers (6)
Päivi RautiainenHilkka TirkkonenTiina Laatikainen. (2018) Glycemic Control in Adult Type 1 Diabetes Patients with Insulin Glargine, Insulin Detemir, or Continuous Subcutaneous Insulin Infusion in Daily Practice. Diabetes Technology & Therapeutics 20:5, pages 363-369.
Crossref
Crossref
Asrul Akmal Shafie, Chin Hui Ng, Yui Ping Tan & Nathorn Chaiyakunapruk. (2016) Systematic Review of the Cost Effectiveness of Insulin Analogues in Type 1 and Type 2 Diabetes Mellitus. PharmacoEconomics 35:2, pages 141-162.
Crossref
Crossref
Phil McEwan, Hayley Bennett, Jonathan Fellows, Jennifer Priaulx & Klas Bergenheim. (2016) The Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus. PLOS ONE 11:9, pages e0162441.
Crossref
Crossref
Stephen Brown, Yazid N. Al Hamarneh, Ross T. Tsuyuki, Kimberley Nehme & Luc Sauriol. (2016) Economic analysis of insulin initiation by pharmacists in a Canadian setting. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 149:3, pages 130-137.
Crossref
Crossref
Stephen T. Brown, Daniel Grima Grima & Luc Sauriol. (2014) Cost-effectiveness of Insulin Glargine Versus Sitagliptin in Insulin-naïve Patients With Type 2 Diabetes Mellitus. Clinical Therapeutics 36:11, pages 1576-1587.
Crossref
Crossref
Lin Xie, Wenhui Wei, Chunshen Pan, Juan Du & Onur Baser. (2011) A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pens. Advances in Therapy 28:11, pages 1000-1011.
Crossref
Crossref